Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers
Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers
IC 50 values of 16A-MMAE for cancer cell lines. | Download Scientific Diagram
IC 50 values of MMAE, anti-human ADC and anti-mouse ADC in various... | Download Table
In vitro characterization of aMSLN-MMAE ADC. A, FACS | Download Scientific Diagram
Effects of microtubule-inhibiting small molecule and antibody-drug conjugate treatment on differentially-sized A431 squamous carcinoma spheroids | Scientific Reports
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance | bioRxiv
Hydrophilic Monomethyl Auristatin E Derivatives as Novel Candidates for the Design of Antibody-Drug Conjugates
![PDF] Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0f25298f4ae161a992fe71e90bd7c3f1dc38dd35/5-Table1-1.png "PDF] Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy | Semantic Scholar")
PDF] Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy | Semantic Scholar
Cancers | Free Full-Text | Antibody-Drug Conjugate Using Ionized Cys-Linker- MMAE as the Potent Payload Shows Optimal Therapeutic Safety | HTML
Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody–drug conjugate (ADC)
Bioprocess development of antibody-drug conjugate production for cancer treatment | PLOS ONE
E3 MMAE and MMAF drug conjugates are toxic to prostate cancer, but not... | Download Scientific Diagram
m825-MMAE activation by TSCs drives bystander killing. (A) In vitro CM... | Download Scientific Diagram
Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON recep
Hydrophilic Monomethyl Auristatin E Derivatives as Novel Candidates for the Design of Antibody-Drug Conjugates
Figure 7 | Contribution of Nontarget Cells to the Disposition, Antitumor Activity, and Antigen-Independent Toxicity of Antibody–Drug Conjugates | SpringerLink
Monomethyl Auristatin E Phosphate Inhibits Human Prostate Cancer Growth
Cytotoxic effects of MMAE on various tumor cell lines. The HepG2,... | Download Scientific Diagram
Pyridazinediones deliver potent, stable, targeted and efficacious antibody–drug conjugates (ADCs) with a controlled loading of 4 drugs per antibody - RSC Advances (RSC Publishing) DOI:10.1039/C7RA00788D
Untitled
Antibody-drug conjugate and free geldanamycin combination therapy enhances anti-cancer efficacy - ScienceDirect
IC 50 values of 16A-MMAE for cancer cell lines. | Download Scientific Diagram
